October 26, 2022 | Careers
Mercy BioAnalytics, Inc. is a pre-commercial biotechnology company committed to reducing suffering and saving lives through the early detection of cancer. We are looking for a passionate individual to join our mission leading Portfolio Management for product...July 11, 2022 | Press Release
NATICK, MA – July 11, 2022 – Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of experienced biotechnology executive, Dawn Mattoon, PhD, as Chief Operating Officer,...May 27, 2022 | Press Release
Mercy Halo Data Demonstrates Promise of Novel Extracellular Vesicle Biomarker-Based Approach for Early Cancer Detection Natick, MA – May 27, 2022 – Mercy BioAnalytics™, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of...